We are live on ! Find out more
AG

Algert Global Portfolio holdings

AUM $6.65B
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+5.52%
1 Year Est. Return
+53.68%
3 Year Est. Return
+140.8%
5 Year Est. Return
+204.57%
10 Year Est. Return
+1,528.09%
AUM
$4.25B
AUM Growth
+$531M
Cap. Flow
+$516M
Cap. Flow %
12.13%
Top 10 Hldgs %
5.59%
Holding
1,380
New
228
Increased
589
Reduced
316
Closed
227

Top Sells

Rank Stock Value
1
UGI icon
UGI
UGI
+$12.1M
2
CVNA icon
Carvana
CVNA
+$11.2M
3
LPX icon
Louisiana-Pacific
LPX
+$10.1M
4
PI icon
Impinj
PI
+$9.63M
5
FLEX icon
Flex
FLEX
+$9.51M

Sector Composition

Rank Sector Weight
1 Technology 16.24%
2 Financials 15.93%
3 Industrials 15.73%
4 Healthcare 13.02%
5 Consumer Discretionary 12.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTTR
826
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$818K 0.02%
172,558
+26,053
+18% +$124K
GCT icon
827
GigaCloud Technology
GCT
$1.33B
$817K 0.02%
+44,090
New +$1.02M
NTLA icon
828
Intellia Therapeutics
NTLA
$1.55B
$809K 0.02%
69,354
+8,312
+14% +$130K
DHC
829
Diversified Healthcare Trust
DHC
$2.24B
$808K 0.02%
351,097
+43,921
+14% +$129K
HOV icon
830
Hovnanian Enterprises
HOV
$767M
$806K 0.02%
6,025
+435
+8% +$76.2K
MRVI icon
831
Maravai LifeSciences
MRVI
$1.04B
$804K 0.02%
147,459
+45,741
+45% +$294K
UHT
832
Universal Health Realty Income Trust
UHT
$601M
$802K 0.02%
21,542
+1,197
+6% +$48.8K
AZEK
833
DELISTED
The AZEK Co
AZEK
$800K 0.02%
16,847
-102,606
-86% -$4.9M
DNLI icon
834
Denali Therapeutics
DNLI
$3.72B
$795K 0.02%
39,015
-9,615
-20% -$246K
SKYT icon
835
SkyWater Technology
SKYT
$1.51B
$795K 0.02%
57,615
+31,631
+122% +$314K
TMDX icon
836
Transmedics
TMDX
$2.46B
$783K 0.02%
12,554
-26,494
-68% -$2.47M
PUBM icon
837
PubMatic
PUBM
$571M
$781K 0.02%
53,154
-112,365
-68% -$1.74M
CDNA icon
838
CareDx
CDNA
$1.94B
$772K 0.02%
36,040
+7,460
+26% +$181K
TWO
839
Two Harbors Investment
TWO
$1.27B
$769K 0.02%
64,963
+9,373
+17% +$113K
VISN
840
Vistance Networks Inc
VISN
$2.69B
$765K 0.02%
146,745
+92,565
+171% +$518K
JEF icon
841
Jefferies Financial Group
JEF
$12.8B
$764K 0.02%
9,748
-115,134
-92% -$8.28M
LESL icon
842
Leslie's
LESL
$12.4M
$760K 0.02%
17,046
+7,604
+81% +$404K
MD icon
843
Pediatrix Medical
MD
$2.1B
$759K 0.02%
57,835
-55,600
-49% -$768K
LAZ icon
844
Lazard
LAZ
$4.24B
$755K 0.02%
+14,662
New +$785K
XRAY icon
845
Dentsply Sirona
XRAY
$2.55B
$753K 0.02%
+39,650
New +$838K
ROL icon
846
Rollins
ROL
$19B
$747K 0.02%
16,120
-44,006
-73% -$2.16M
HD icon
847
Home Depot
HD
$324B
$742K 0.02%
1,907
+306
+19% +$125K
VLY icon
848
Valley National Bancorp
VLY
$8.01B
$738K 0.02%
+81,492
New +$790K
SASR
849
DELISTED
Sandy Spring Bancorp Inc
SASR
$732K 0.02%
21,723
-37,596
-63% -$1.31M
CBSH icon
850
Commerce Bancshares
CBSH
$8.44B
$731K 0.02%
+12,310
New +$742K

Similar funds

Algert Global's Q4 2024 Portfolio in Review

As of Q4 2024, Algert Global held 1,380 positions worth $4.25B, up 14% from $3.72B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

Algert Global deployed $516M of net new capital in Q4 2024, opening 228 new positions and adding to 589 existing holdings. Its largest new stake was Chord Energy: 124,143 shares worth $14.5M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was UGI, an estimated $12.1M trimmed.

  • Algert Global's largest Q4 2024 buy was Chord Energy: 124,143 shares worth $14.5M.
  • Algert Global added most to Mueller Industries in Q4 2024, an estimated $13.4M increase.
  • Algert Global's biggest Q4 2024 reduction was UGI, cutting an estimated $12.1M.
  • Algert Global fully exited Carvana in Q4 2024, selling an estimated $11.2M.
  • Algert Global's ten largest holdings make up 5.6% of its $4.25B portfolio in Q4 2024.
  • Algert Global opened 228 new positions and closed 227 in Q4 2024.
  • Algert Global's portfolio value rose 14% quarter-over-quarter to $4.25B.

Based on Algert Global's 13F filing for Q4 2024, filed 14 Feb 2025.